complicates fda filing...most certainly
Yes, FDA is always concerned on safety issues. See BMTI after after panel negative comments about saftey and see now where it is closed today. $14 - $6.64SAFETY A PRIME CONCERN FOR FDA.
Its cancer, untreatable cancer. Hello. really!!
You heard the clinicians say that the AE profile is moderate, similar to other agents that impact angiogenesis?